{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "17185195",
  "DateCompleted": {
    "Year": "2007",
    "Month": "03",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2006",
    "Month": "12",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1053-4296",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "1",
        "PubDate": {
          "Year": "2007",
          "Month": "Jan"
        }
      },
      "Title": "Seminars in radiation oncology",
      "ISOAbbreviation": "Semin Radiat Oncol"
    },
    "ArticleTitle": "The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response.",
    "Pagination": {
      "StartPage": "29",
      "EndPage": "37",
      "MedlinePgn": "29-37"
    },
    "Abstract": {
      "AbstractText": [
        "Computed tomography (CT) and endoscopy/endoscopic ultrasonography are usually performed to initially stage patients with esophageal cancer, to determine primary tumor response, and to detect nodal and distant metastases after preoperative therapy. Positron-emission tomography (PET) with [18F]-fluoro-2-deoxy-D-glucose and integrated CT-PET are useful in the initial staging of patients with esophageal cancer as well as in the prediction of pathologic response, disease-free interval, and overall survival after preoperative therapy. Importantly, integrated CT-PET imaging decreases the number of futile attempts at surgical resection, mainly because of the detection of occult distant metastases. The following sections review the use of integrated CT-PET imaging in determining the T, N, and M descriptors of the American Joint Commission on Cancer's 2002 guidelines for pathologic and clinical staging at initial diagnosis and after chemoradiation therapy in those patients being considered for surgical resection."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. jerasmus@di.mdacc.tmc.edu <jerasmus@di.mdacc.tmc.edu>"
          }
        ],
        "LastName": "Erasmus",
        "ForeName": "Jeremy J",
        "Initials": "JJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Munden",
        "ForeName": "Reginald F",
        "Initials": "RF"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Semin Radiat Oncol",
    "NlmUniqueID": "9202882",
    "ISSNLinking": "1053-4296"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Contrast Media"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Contrast Media"
    },
    {
      "QualifierName": [
        "diagnosis",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Esophageal Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Lymphatic Metastasis"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "Neoplasm Metastasis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Staging"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Positron-Emission Tomography"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Tomography, X-Ray Computed"
    }
  ],
  "NumberOfReferences": "68"
}